FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elizabeth Jaffee

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Procedures

Physiology

Co-author Network

Publications

TOP 3
Lei Zheng; Elizabeth M Jaffee; Jing Xue; Aida Habtezion
Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.
Bridget Keenan; Elizabeth M Jaffee
Immunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance.
Daniel Laheru; Barbara A Biedrzycki; Elizabeth M Jaffee
Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elizabeth Jaffee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lei Zheng; Elizabeth M Jaffee; Jing Xue; Aida Habtezion
Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.
Gastroenterology 2013;144(6):1230-40.
2013: Bridget Keenan; Elizabeth M Jaffee
Immunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance.
Annals of the New York Academy of Sciences 2013;1284(1):12-6.
2013: Daniel Laheru; Barbara A Biedrzycki; Elizabeth M Jaffee
Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.
Methods in molecular biology (Clifton, N.J.) 2013;980():175-203.
2013: Elaine Bigelow; Lieping Chen; Elizabeth M Jaffee; Janis M Taube; Annie Wu; Haiying Xu; Allison Yager; Robert A Anders; Katherine M Bever; Lei Zheng
Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue.
Journal of visualized experiments : JoVE 2013;(71):.
2012: Min-Sik Kim; Sarada V Kuppireddy; Anirban Maitra; Sruthi Sakamuri; Mukul Singal; Shantal G Tankala; Victor E Velculescu; Lavanya Balakrishnan; Derese Getnet; Renu Goel; Michael Goggins; H C Harsha; Ralph Hruban; Christine A Iacobuzio-Donahue; Harrys K C Jacob; Elizabeth M Jaffee; Manoj K Kashyap; Akhilesh Pandey
Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs).
Journal of proteome research 2012;11(11):5556-63.
2012: Kevin C Soares; Lei Zheng; BARISH EDIL; Elizabeth M Jaffee
Vaccines for pancreatic cancer.
Cancer journal (Sudbury, Mass.) 2012;18(6):642-52.
2012: Qingfei Wang; Yi Xiao; Samuel W Brady; Hailiang Ge; Gabriel N Hortobagyi; Elizabeth M Jaffee; Ping Li; Shau-Hsuan Li; William J Muller; Ozgur Sahin; Hai Wang; Dihua Yu
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer.
Cancer research 2012;72(17):4417-28.
2012: DUNG LE; Elizabeth M Jaffee
Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective.
Cancer research 2012;72(14):3439-44.
2012: Bridget P Keenan; Elizabeth M Jaffee
Whole cell vaccines--past progress and future strategies.
Seminars in oncology 2012;39(3):276-86.
2012: Richard Tuli; John Wong; Michael Armour; Amanda Blackford; Theodore L DeWeese; Amy Hacker-Prietz; Elizabeth M Jaffee; Ashley Leubner; Juvenal Reyes; Andrew Surmak; ERIK TRYGGESTAD; JOSEPH HERMAN
Development of a novel preclinical pancreatic cancer research model: bioluminescence image-guided focal irradiation and tumor monitoring of orthotopic xenografts.
Translational oncology 2012;5(2):77-84.
2012: Thomas Blankenstein; Pierre G Coulie; Eli Gilboa; Elizabeth M Jaffee
The determinants of tumour immunogenicity.
Nature reviews. Cancer 2012;12(4):307-13.
2012: DUNG LE; Jordana Levine; Jana-Lynn Louis; Eric Lutz; Shruti Mathur; Bentley Moyer; Aimee Luck Murphy; John Nemunaitis; Ran Nir-Paz; Alice Pons; Daniel H Sterman; Elizabeth Sugar; Dirk G Brockstedt; Andrea L Cox; Thomas W Dubensky; Joseph E Eiden; Martin Giedlin; Johannes Hampl; Raffit Hassan; PETER ILLEI; Elizabeth M Jaffee; Daniel Laheru
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(3):858-68.
2012: Vivian L Weiss; Chelsea M Black; Elizabeth M Jaffee; Theodore S Kouo; Timothy H Lee; George Sgouros; Hong Song; TD Armstrong
Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells.
PloS one 2012;7(2):e31962.
2011: DUNG LE; Brian H Ladle; Timothy Lee; Vivian Weiss; Xiaosai Yao; Ashley Leubner; TD Armstrong; Elizabeth M Jaffee
CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response.
International journal of cancer. Journal international du cancer 2011;129(3):636-47.
2011: Lesley A Mathews; Xiaohu Zhang; Stephanie M Cabarcas; Elaine M Hurt; Elizabeth M Jaffee; William L Farrar
Increased expression of DNA repair genes in invasive human pancreatic cancer cells.
Pancreas 2011;40(5):730-9.
2011: Jennifer N Uram; Chelsea M Black; Emilee Flynn; LANQING HUANG; TD Armstrong; Elizabeth M Jaffee
Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(7):3847-57.
2011: Eric Lutz; Charles J Yeo; Keith D Lillemoe; Barbara A Biedrzycki; BARRY KOBRIN; JOSEPH HERMAN; Elizabeth Sugar; Steven Piantadosi; John L Cameron; Sara Solt; Beth Onners; Irena Tartakovsky; Miri Choi; Rajni Sharma; PETER ILLEI; Ralph Hruban; Ross A Abrams; DUNG LE; Elizabeth M Jaffee; Daniel Laheru
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.
Annals of surgery 2011;253(2):328-35.
2011: Bernard A Fox; Thomas F Gajewski; Jerome Galon; Jared A Gollob; Cécile Gouttefangeas; Fabio Grizzi; Michele Guida; Leif Håkansson; Kristen Hege; Ronald B Herberman; F Stephen Hodi; Axel Hoos; Christoph Huber; Patrick Hwu; Kohzoh Imai; Elizabeth M Jaffee; Sylvia Janetzki; Carl H June; Pawel Kalinski; Howard L Kaufman; Koji Kawakami; Yutaka Kawakami; Ulrich Keilholtz; Samir N Khleif; Rolf Kiessling; Beatrix Kotlan; Guido Kroemer; Rejean Lapointe; Hyam I Levitsky; Michael T Lotze; Cristina Maccalli; Michele Maio; Francesco M Marincola; Jens-Peter Marschner; Michael J Mastrangelo; Giuseppe Masucci; Ignacio Melero; Cornelius Melief; William Murphy; Brad Nelson; Andrea Nicolini; Michael I Nishimura; Jill O'Donnell-Tormey; Kunle Odunsi; Pamela S Ohashi; Lloyd J Old; Christian Ottensmeier; Michael Papamichail; Giorgio Parmiani; Graham Pawelec; Enrico Proietti; Shukui Qin; Robert Rees; Antoni Ribas; Ruggero Ridolfi; Gerd Ritter; Licia Rivoltini; Pedro J Romero; Mohamed L Salem; Dolores J Schendel; Rik J Scheper; Barbara Seliger; Padmanee Sharma; Hiroshi Shiku; Harpreet Singh-Jasuja; Wenru Song; Per Thor Straten; Hideaki Tahara; Zhigang Tian; Sjoerd H van der burg; Paul von Hoegen; Ena Wang; Marij Jp Welters; JON WIGGINTON; Hauke Winter; Tara Withington; Jedd D Wolchok; Weihua Xiao; Laurence Zitvogel; Heinz Zwierzina; Steinar Aamdal; James P Allison; Paolo Antonio Ascierto; Michael B Atkins; Jirina Bartunkova; Lothar Bergmann; Neil Berinstein; Cristina C Bonorino; Ernest Borden; Jonathan L Bramson; Cedrik M Britten; Lisa H Butterfield; Xuetao Cao; William E Carson; Alfred E Chang; Dainius Characiejus; A Raja Choudhury; George Coukos; Tanja de Gruijl; Robert O Dillman; Harry Dolstra; Glenn Dranoff; Lindy G Durrant; James H Finke; Mary L Disis
Defining the critical hurdles in cancer immunotherapy.
Journal of translational medicine 2011;9(1):214.
2011: Lei Zheng; Kelly Foley; LANQING HUANG; Ashley Leubner; Guanglan Mo; Kelly Olino; BARISH EDIL; Masamichi Mizuma; Rajni Sharma; DUNG LE; Robert A Anders; PETER ILLEI; Jennifer E Van Eyk; Anirban Maitra; Daniel Laheru; Elizabeth M Jaffee
Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.
PloS one 2011;6(4):e19390.
2011: James M Balwit; Pierre G Coulie; Thomas F Gajewski; Elizabeth M Jaffee; Pawel Kalinski; Vernon K Sondak; Francesco M Marincola
Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.
Journal of translational medicine 2011;9():60.
2010: Robert L Ferris; Elizabeth M Jaffee; Soldano Ferrone
Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(28):4390-9.
2010: DUNG LE; Drew M Pardoll; Elizabeth M Jaffee
Cellular vaccine approaches.
Cancer journal (Sudbury, Mass.) 2010;16(4):304-10.
2010: Lukas W Pfannenstiel; Samuel S K Lam; Leisha A Emens; Elizabeth M Jaffee; TD Armstrong
Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice.
Cellular immunology 2010;263(1):79-87.
2009: Leisha A Emens; Justin M Asquith; James M Leatherman; BARRY KOBRIN; Silvia Petrik; Marina Laiko; Joy Levi; Maithili M Daphtary; Barbara A Biedrzycki; Antonio C Wolff; Vered Stearns; Mary L Disis; Xiaobu Ye; Steven Piantadosi; John H Fetting; Nancy E Davidson; Elizabeth M Jaffee
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):5911-8.
2009: Naomi Kitamura; Satoshi Murata; Tomoyuki Ueki; Eiji Mekata; Richard T. Reilly; Elizabeth M Jaffee; Tohru Tani
OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
International journal of cancer. Journal international du cancer 2009;125(3):630-8.
2009: Amanda Blackford; Oscar K Serrano; Christopher L Wolfgang; Giovanni Parmigiani; Siân Jones; Xiaosong Zhang; DONALD PARSONS; Jimmy Cheng-Ho Lin; Rebecca J Leary; James R Eshleman; Michael Goggins; Elizabeth M Jaffee; Christine A Iacobuzio-Donahue; Anirban Maitra; John L Cameron; Kelly Olino; Richard D Schulick; Jordan Winter; JOSEPH HERMAN; Daniel Laheru; Alison P Klein; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Ralph Hruban
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(14):4674-9.
2009: Amanda Blackford; Giovanni Parmigiani; Thomas W Kensler; Christopher L Wolfgang; Siân Jones; Xiaosong Zhang; DONALD PARSONS; Jimmy Cheng-Ho Lin; Rebecca J Leary; James R Eshleman; Michael Goggins; Elizabeth M Jaffee; Christine A Iacobuzio-Donahue; Anirban Maitra; Alison P Klein; John L Cameron; Kelly Olino; Richard D Schulick; Jordan Winter; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler; Ralph Hruban
Genetic mutations associated with cigarette smoking in pancreatic cancer.
Cancer research 2009;69(8):3681-8.
2009: Siân Jones; Ralph Hruban; Mihoko Kamiyama; Michael Borges; Xiaosong Zhang; DONALD PARSONS; Jimmy Cheng-Ho Lin; Emily Palmisano; Kieran Brune; Elizabeth M Jaffee; Christine A Iacobuzio-Donahue; Anirban Maitra; Giovanni Parmigiani; Scott E Kern; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; James R Eshleman; Michael Goggins; Alison P Klein
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Science (New York, N.Y.) 2009;324(5924):217.
2009: Mary L Disis; H Bernhard; Elizabeth M Jaffee
Use of tumour-responsive T cells as cancer treatment.
Lancet 2009;373(9664):673-83.
2008: Ihid C Leao; Priya Ganesan; TD Armstrong; Elizabeth M Jaffee
Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma.
Clinical and translational science 2008;1(3):228-39.
2008: Tomoharu Miyashita; Furhawn A Shah; guy marti; TD Armstrong; Jiaai Wang; Pramod Bonde; Michael K Gibson; Kiyoshi Yoshimura; Elizabeth Montgomery; Mark D Duncan; Elizabeth M Jaffee; John W Harmon
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus setting.
Digestive diseases and sciences 2008;53(11):2858-67.
2008: Siân Jones; Xiaosong Zhang; DONALD PARSONS; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; Hirohiko Kamiyama; Antonio Jimeno; Seung-Mo Hong; BAOJIN FU; Ming-Tseh Lin; Eric S Calhoun; Mihoko Kamiyama; Kimberly Walter; Tatiana Nikolskaya; Yuri Nikolsky; James Hartigan; Douglas R Smith; Manuel Hidalgo; Steven D Leach; Alison P Klein; Elizabeth M Jaffee; Michael Goggins; Anirban Maitra; Christine A Iacobuzio-Donahue; James R Eshleman; Scott E Kern; Ralph Hruban; Rachel Karchin; Nickolas Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
Science (New York, N.Y.) 2008;321(5897):1801-6.
2008: JOSEPH HERMAN; Michael J Swartz; Charles C Hsu; Jordan Winter; Timothy M Pawlik; Elizabeth Sugar; Ray Robinson; Daniel Laheru; Elizabeth M Jaffee; Ralph Hruban; Kurtis A Campbell; Christopher L Wolfgang; Fariba Asrari; Ross C Donehower; Manuel Hidalgo; Luis Alberto Diaz; Charles Yeo; John L Cameron; Richard D Schulick; Ross Abrams
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3503-10.
2008: Peter S Kim; TD Armstrong; Hong Song; Matthew E Wolpoe; Vivian Weiss; Elizabeth A Manning; LANQING HUANG; Satoshi Murata; George Sgouros; Leisha A Emens; Richard T. Reilly; Elizabeth M Jaffee
Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs.
The Journal of clinical investigation 2008;118(5):1700-11.
2008: Daniel Laheru; Eric Lutz; James Burke; Barbara A Biedrzycki; Sara Solt; Beth Onners; Irena Tartakovsky; John Nemunaitis; DUNG LE; Elizabeth Sugar; Kristen Hege; Elizabeth M Jaffee
Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1455-63.
2008: Tomoharu Miyashita; Furhawn A Shah; guy marti; Jiaai Wang; TD Armstrong; Pramod Bonde; Michael K Gibson; Kiyoshi Yoshimura; Elizabeth Montgomery; Mark D Duncan; Elizabeth M Jaffee; John W Harmon
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a Pre-Barrett's esophagus setting.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2008;12(1):2-7; discussion 7-9.
2007: Marion Couch; Robert L Ferris; Joseph A Brennan; Wayne M Koch; Elizabeth M Jaffee; Michael S Leibowitz; Gerald Nepom; Henry A Erlich; David Sidransky
Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):7199-206.
2007: Timothy P Moran; Joseph E Burgents; Brian Long; Ivana Ferrer; Elizabeth M Jaffee; Roland Tisch; Robert E Johnston; Jonathan S Serody
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice.
Vaccine 2007;25(36):6604-12.
2007: Elizabeth A Manning; John G M Ullman; James M Leatherman; Justin M Asquith; Timothy R Hansen; TD Armstrong; Daniel J Hicklin; Elizabeth M Jaffee; Leisha A Emens
A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(13):3951-9.
2007: George C Prendergast; Elizabeth M Jaffee
Cancer immunologists and cancer biologists: why we didn't talk then but need to now.
Cancer research 2007;67(8):3500-4.
2007: Pramod Bonde; Guoping Sui; Surajit Dhara; Jiaai Wang; Apoorv Broor; Irene F Kim; John E Wiley; guy marti; Mark D Duncan; Elizabeth M Jaffee; Elizabeth Montgomery; Anirban Maitra; John W Harmon
Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
The Journal of thoracic and cardiovascular surgery 2007;133(3):763-9.
2007: Ken-Yu Lin; Dan Lu; Chien-Fu Hung; Shiwen Peng; LANQING HUANG; Chunfa Jie; Francisco Martinez Murillo; Jesse Rowley; Ya-Chea Tsai; Liangmei He; Dae-Jin Kim; Elizabeth M Jaffee; Drew M Pardoll; Tzyy-choou Wu
Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion.
Cancer research 2007;67(4):1832-41.
2007: Raffit Hassan; Wolfgang Ebel; Eric Routhier; Rina Patel; J Bradford Kline; Jingli Zhang; Qimin Chao; Sara Jacob; Howard Turchin; Lester Gibbs; Martin D Phillips; Shiyama Mudali; Christine A Iacobuzio-Donahue; Elizabeth M Jaffee; Maria Moreno; Ira Pastan; Philip M Sass; Nicholas C Nicolaides; Luigi Grasso
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.
Cancer immunity 2007;7():20.
2007: Constance A Griffin; Laura Morsberger; Anita L Hawkins; Mary H Haddadin; Ankita Patel; T Ried; E Schrock; Elizabeth J. Perlman; Elizabeth M Jaffee
Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.
Cytogenetic and genome research 2007;118(2-4):148-56.
2006: Satoshi Murata; Scott L Kominsky; Mustafa Vali; Zhe Zhang; Elizabeth Garrett-Mayer; Dorian Korz; David L Huso; Sharyn D Baker; James Barber; Elizabeth M Jaffee; Richard T. Reilly; Saraswati Sukumar
Ductal access for prevention and therapy of mammary tumors.
Cancer research 2006;66(2):638-45.
2006: Satoshi Murata; Brian H Ladle; Peter S Kim; Eric R Lutz; Matthew E Wolpoe; Susan E Ivie; Holly M Smith; TD Armstrong; Leisha A Emens; Elizabeth M Jaffee; Richard T. Reilly
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(2):974-83.
2006: Charles G Drake; Elizabeth M Jaffee; Drew M Pardoll
Mechanisms of immune evasion by tumors.
Advances in immunology 2006;90():51-81.
2005: Daniel Laheru; Drew M Pardoll; Elizabeth M Jaffee
Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunology.
Molecular cancer therapeutics 2005;4(11):1645-52.
2005: Leisha A Emens; Elizabeth M Jaffee
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.
Cancer research 2005;65(18):8059-64.
2005: Reshma Singh; Mary Dominiecki; Elizabeth M Jaffee; Yvonne Paterson
Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(6):3663-73.
2005: Sara Gandini; Albert B Lowenfels; Elizabeth M Jaffee; TD Armstrong; Patrick Maisonneuve
Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(8):1908-16.
2005: Josef Mautner; Elizabeth M Jaffee; Drew M Pardoll
Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigens.
International journal of cancer. Journal international du cancer 2005;115(5):752-9.
2005: Daniel Laheru; Elizabeth M Jaffee
Immunotherapy for pancreatic cancer - science driving clinical progress.
Nature reviews. Cancer 2005;5(6):459-67.
2005: Anne M Ercolini; Brian H Ladle; Elizabeth A Manning; Lukas W Pfannenstiel; TD Armstrong; Jean-Pascal H Machiels; Joan G Bieler; Leisha A Emens; Richard T. Reilly; Elizabeth M Jaffee
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response.
The Journal of experimental medicine 2005;201(10):1591-602.
2005: Leisha A Emens; Richard T. Reilly; Elizabeth M Jaffee
Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity.
Endocrine-related cancer 2005;12(1):1-17.
2005: Xianzheng Zhou; Do Youn Jun; Amy Morck Thomas; Xin Huang; LANQING HUANG; Josef Mautner; Wa Mo; Paul F Robbins; Drew M Pardoll; Elizabeth M Jaffee
Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine.
Cancer research 2005;65(3):1079-88.
2005: Patricia M Alli; Michael L Pinn; Elizabeth M Jaffee; Jill M McFadden; Francis P Kuhajda
Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.
Oncogene 2005;24(1):39-46.
2005: Leisha A Emens; Richard T. Reilly; Elizabeth M Jaffee
Cancer vaccines in combination with multimodality therapy.
Cancer treatment and research 2005;123():227-45.
2005: JANICE DAVIS SPROUL; M P Harris; Nancy E Davidson; BARRY KOBRIN; Elizabeth M Jaffee; Leisha A Emens
Cost-effective manufacture of an allogeneic GM-CSF-secreting breast tumor vaccine in an academic cGMP facility.
Cytotherapy 2005;7(1):46-56.
2005: Daniel Laheru; Barbara A Biedrzycki; Amy M Thomas; Elizabeth M Jaffee
Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.
Methods in molecular medicine 2005;103():299-327.
2004: Amy Morck Thomas; Lynn M Santarsiero; Eric R Lutz; TD Armstrong; Yi-Cheng Chen; LANQING HUANG; Daniel Laheru; Michael Goggins; Ralph Hruban; Elizabeth M Jaffee
Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients.
The Journal of experimental medicine 2004;200(3):297-306.
2004: Leisha A Emens; Deborah K Armstrong; Barbara A Biedrzycki; Nancy E Davidson; JANICE DAVIS SPROUL; John H Fetting; Elizabeth M Jaffee; Beth Onners; Steven Piantadosi; Richard T. Reilly; Vered Stearns; Irena Tartakovsky; Kala Visvanathan; Antonio C Wolff
A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin.
Human gene therapy 2004;15(3):313-37.
2004: Leisha A Emens; Richard T. Reilly; Elizabeth M Jaffee
Augmenting the potency of breast cancer vaccines: combined modality immunotherapy.
Breast disease 2004;20():13-24.
2003: Leisha A Emens; Elizabeth M Jaffee
Toward a breast cancer vaccine: work in progress.
Oncology (Williston Park, N.Y.) 2003;17(9):1200-11; discussion 1214, 1217-8.
2003: Matthew E Wolpoe; Eric R Lutz; Anne M Ercolini; Satoshi Murata; Susan E Ivie; Elizabeth Garrett-Mayer; Leisha A Emens; Elizabeth M Jaffee; Richard T. Reilly
HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(4):2161-9.
2003: Marion Couch; John K Saunders; Bert W O'Malley; Drew M Pardoll; Elizabeth M Jaffee
Spatial distribution of tumor vaccine improves efficacy.
The Laryngoscope 2003;113(8):1401-5.
2003: Xianzheng Zhou; Yan Cui; Xin Huang; Zhiwei Yu; Amy M Thomas; Zhaohui Ye; Drew M Pardoll; Elizabeth M Jaffee; Linzhao Cheng
Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
Human gene therapy 2003;14(11):1089-105.
2003: Leisha A Emens; Elizabeth M Jaffee
Cancer vaccines: an old idea comes of age.
Cancer biology & therapy 2003;2(4 Suppl 1):S161-8.
2003: Falk Nimmerjahn; Slavoljub Milosevic; Uta Behrends; Elizabeth M Jaffee; Drew M Pardoll; Georg W Bornkamm; Josef Mautner
Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy.
European journal of immunology 2003;33(5):1250-9.
2003: Anne M Ercolini; Jean-Pascal H Machiels; Yi Cheng Chen; Jill E Slansky; Martin Giedlen; Richard T. Reilly; Elizabeth M Jaffee
Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(8):4273-80.
2003: Christine A Iacobuzio-Donahue; Anirban Maitra; Mari Olsen; Anson W Lowe; N Tjarda van Heek; Christophe Rosty; Kim Walter; Norihiro Sato; Antony Parker; Raheela Ashfaq; Elizabeth M Jaffee; Byungwoo Ryu; Jessa Jones; James R Eshleman; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban; Patrick O Brown; Michael Goggins
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays.
The American journal of pathology 2003;162(4):1151-62.
2003: Marion Couch; John K Saunders; Bert W O'Malley; Drew M Pardoll; Elizabeth M Jaffee
Genetically engineered tumor cell vaccine in a head and neck cancer model.
The Laryngoscope 2003;113(3):552-6.
2003: Stephan Scheffer; Heike Nave; Firouzeh Korangy; Karola Schlote; Reinhard Pabst; Elizabeth M Jaffee; Michael P Manns; Tim F Greten
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.
International journal of cancer. Journal international du cancer 2003;103(2):205-11.
2002: TD Armstrong; Elizabeth M Jaffee
Cytokine modified tumor vaccines.
Surgical oncology clinics of North America 2002;11(3):681-96.
2002: Leisha A Emens; Elizabeth M Jaffee
To live or not to live: that depends on GAGE?
Cancer biology & therapy 2002;1(4):388-90.
2002: Theresa Pluth Yeo; Ralph Hruban; Steven D Leach; Robb E Wilentz; Taylor A Sohn; Scott E Kern; Christine A Iacobuzio-Donahue; Anirban Maitra; Michael Goggins; Marcia Canto; Ross A. Abrams; Daniel Laheru; Elizabeth M Jaffee; Manuel Hidalgo; Charles J Yeo
Pancreatic cancer.
Current problems in cancer 2002;26(4):176-275.
2002: Elizabeth M Jaffee; Ralph Hruban; Marcia Canto; Scott E Kern
Focus on pancreas cancer.
Cancer cell 2002;2(1):25-8.
2002: Takashi Ueki; Kimberly M Walter; Halcyon Skinner; Elizabeth M Jaffee; Ralph Hruban; Michael Goggins
Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
Oncogene 2002;21(13):2114-7.
2002: Edus H Warren; Scott S Tykodi; Makoto Murata; Brenda M Sandmaier; Rainer Storb; Elizabeth M Jaffee; R Childs; J A Thompson; Philip D Greenberg; Stanley R Riddell
T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma.
Cytotherapy 2002;4(5):441.
2002: Richard T. Reilly; Jean-Pascal H Machiels; Leisha A Emens; Elizabeth M Jaffee
Cytokine gene-modified cell-based cancer vaccines.
Methods in molecular medicine 2002;69():233-57.
2001: Pedram Argani; Christine A Iacobuzio-Donahue; Byungwoo Ryu; Christophe Rosty; Michael Goggins; Robb E Wilentz; S R Murugesan; Steven D Leach; Elizabeth M Jaffee; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3862-8.
2001: Daniel Laheru; Barbara A Biedrzycki; Elizabeth M Jaffee
Immunologic approaches to the management of pancreatic cancer.
Cancer journal (Sudbury, Mass.) 2001;7(4):324-37.
2001: John G Wesseling; Piter J Bosma; Victor Krasnykh; Elena Kashentseva; Jerry L Blackwell; Paul N Reynolds; H Li; M Parameshwar; Selwyn M Vickers; Elizabeth M Jaffee; K Huibregtse; David T Curiel; Igor Dmitriev
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
Gene therapy 2001;8(13):969-76.
2001: Denise Golgher; Firouzeh Korangy; B Gao; Kevin Gorski; Elizabeth M Jaffee; Michael Edidin; Drew M Pardoll; Tim Elliott
An immunodominant MHC class II-restricted tumor antigen is conformation dependent and binds to the endoplasmic reticulum chaperone, calreticulin.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(1):147-55.
2001: Scott E Kern; Ralph Hruban; Michael A Hollingsworth; R Brand; Thomas Adrian; Elizabeth M Jaffee; M A Tempero
A white paper: the product of a pancreas cancer think tank.
Cancer research 2001;61(12):4923-32.
2001: Pedram Argani; Christophe Rosty; Robert E Reiter; Robb E Wilentz; S R Murugesan; Steven D Leach; Byungwoo Ryu; Halcyon Skinner; Michael Goggins; Elizabeth M Jaffee; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.
Cancer research 2001;61(11):4320-4.
2001: T F Greten; Elizabeth M Jaffee
Cancer vaccines.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 2001;Chapter 13():Unit 13.8.
2001: Jean-Pascal H Machiels; Richard T. Reilly; Leisha A Emens; Anne M Ercolini; RY Lei; D Weintraub; FI Okoye; Elizabeth M Jaffee
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.
Cancer research 2001;61(9):3689-97.
2001: Leisha A Emens; Jean-Pascal H Machiels; Richard T. Reilly; Elizabeth M Jaffee
Chemotherapy: friend or foe to cancer vaccines?
Current opinion in molecular therapeutics 2001;3(1):77-84.
2001: Richard T. Reilly; Jean-Pascal H Machiels; Leisha A Emens; Anne M Ercolini; FI Okoye; RY Lei; D Weintraub; Elizabeth M Jaffee
The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
Cancer research 2001;61(3):880-3.
2001: Richard T. Reilly; Leisha A Emens; Elizabeth M Jaffee
Humoral and cellular immune responses: independent forces or collaborators in the fight against cancer?
Current opinion in investigational drugs (London, England : 2000) 2001;2(1):133-5.
2001: Elizabeth M Jaffee; Ralph Hruban; Barbara A Biedrzycki; Daniel Laheru; K Schepers; P R Sauter; M Goemann; JoAnn Coleman; Louise B. Grochow; Ross C Donehower; Keith D Lillemoe; Seamus O'Reilly; Ross A. Abrams; Drew M Pardoll; John L Cameron; Charles J Yeo
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):145-56.
2000: Anuradha Chakravarthy; Ross A. Abrams; Charles J Yeo; L T Korman; Ross C Donehower; Ralph Hruban; M L Zahurek; Louise B. Grochow; Seamus O'Reilly; H Hurwitz; Elizabeth M Jaffee; Keith D Lillemoe; John L Cameron
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
International journal of radiation oncology, biology, physics 2000;48(4):1089-96.
2000: Jill E Slansky; FM Rattis; L F Boyd; Tarek M Fahmy; Elizabeth M Jaffee; Jonathan P Schneck; David Margulies; Drew M Pardoll
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.
Immunity 2000;13(4):529-38.
2000: Matthew G Ewend; R C Thompson; R Anderson; AK Sills; K Staveley-O'Carroll; Betty M. Tyler; Justin Hanes; Daniel J Brat; M Thomas; Elizabeth M Jaffee; Drew M Pardoll; Henry Brem
Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(4):438-48.
2000: Richard T. Reilly; M B Gottlieb; Anne M Ercolini; Jean-Pascal H Machiels; C E Kane; FI Okoye; W J Muller; K H Dixon; Elizabeth M Jaffee
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
Cancer research 2000;60(13):3569-76.
2000: Venu Raman; S A Martensen; D Reisman; Ella Evron; W F Odenwald; Elizabeth M Jaffee; J Marks; Saraswati Sukumar
Compromised HOXA5 function can limit p53 expression in human breast tumours.
Nature 2000;405(6789):974-8.
2000: Daniel Laheru; Elizabeth M Jaffee
Potential role of tumor vaccines in GI malignancies.
Oncology (Williston Park, N.Y.) 2000;14(2):245-56; discussion 259-60, 265.
2000: S Ferrone; J F Finerty; Elizabeth M Jaffee; Gary Nabel
How much longer will tumour cells fool the immune system?
Immunology today 2000;21(2):70-2.
2000: Francesco M Marincola; Elizabeth M Jaffee; D J Hicklin; S Ferrone
Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.
Advances in immunology 2000;74():181-273.
1999: Tim F Greten; Elizabeth M Jaffee
Cancer vaccines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):1047-60.
1999: Elizabeth M Jaffee
Immunotherapy of cancer.
Annals of the New York Academy of Sciences 1999;886():67-72.
1998: Michael Goggins; A Lietman; R E Miller; Charles J Yeo; Elizabeth M Jaffee; J Coleman; S O'Reilly; B Cullen; John L Cameron; Scott E Kern; Ralph Hruban
Use and benefits of a Web site for pancreatic cancer.
JAMA : the journal of the American Medical Association 1998;280(15):1309-10.
1998: Elizabeth M Jaffee; RHODA ABRAMS; John L Cameron; Ross C Donehower; M Duerr; J Gossett; Tim F Greten; Louise B. Grochow; Ralph Hruban; Scott E Kern; Keith D Lillemoe; Seamus O'Reilly; Drew M Pardoll; Henry A Pitt; Patricia A Sauter; C Weber; C Yeo
A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma.
Human gene therapy 1998;9(13):1951-71.
1998: Tim F Greten; Jill E Slansky; Ryuji Kubota; Samantha S Soldan; Elizabeth M Jaffee; Thomas P Leist; Drew M Pardoll; Steven Jacobson; Jonathan P Schneck
Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7568-73.
1998: Elizabeth M Jaffee; Mieke Schutte; J Gossett; Laura Morsberger; Adam J. Adler; M Thomas; Tim F Greten; Ralph Hruban; Charles J Yeo; Constance A Griffin
Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials.
The cancer journal from Scientific American 1998;4(3):194-203.
1998: M C Thomas; Tim F Greten; Drew M Pardoll; Elizabeth M Jaffee
Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine.
Human gene therapy 1998;9(6):835-43.
1997: Elizabeth M Jaffee; Drew M Pardoll
Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines.
Methods (San Diego, Calif.) 1997;12(2):143-53.
1997: ME Rosenfeld; S M Vickers; D Raben; M Wang; L Sampson; M Feng; Elizabeth M Jaffee; David T Curiel
Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene.
Annals of surgery 1997;225(5):609-18; discussion 618-20.
1997: Jonathan W Simons; Elizabeth M Jaffee; CE Weber; Hyam I Levitsky; William G Nelson; Michael A Carducci; A J Lazenby; LK Cohen; C C Finn; Shirley Clift; K M Hauda; Lisa A Beck; KM Leiferman; A H Owens; Steven Piantadosi; Glenn Dranoff; Richard C Mulligan; Drew M Pardoll; Fray F Marshall
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.
Cancer research 1997;57(8):1537-46.
1996: R C Thompson; Drew M Pardoll; Elizabeth M Jaffee; M G Ewend; M C Thomas; Betty M. Tyler; Henry Brem
Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(6):405-13.
1996: Elizabeth M Jaffee; Drew M Pardoll
Murine tumor antigens: is it worth the search?
Current opinion in immunology 1996;8(5):622-7.
1996: Alex Yee-Chen Huang; PH Gulden; Amina S Woods; M C Thomas; C D Tong; W Wang; Victor H Engelhard; Gary R Pasternack; Robert J Cotter; D Hunt; Drew M Pardoll; Elizabeth M Jaffee
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(18):9730-5.
1996: Elizabeth M Jaffee; M C Thomas; Alex Yee-Chen Huang; K M Hauda; Hyam I Levitsky; Drew M Pardoll
Enhanced immune priming with spatial distribution of paracrine cytokine vaccines.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(3):176-83.
1995: Tzyy-choou Wu; Alex Yee-Chen Huang; Elizabeth M Jaffee; Hyam I Levitsky; Drew M Pardoll
A reassessment of the role of B7-1 expression in tumor rejection.
The Journal of experimental medicine 1995;182(5):1415-21.
1995: Elizabeth M Jaffee; Audrey Lazenby; J Meurer; F Marshall; K M Hauda; C Counts; H Hurwitz; Jonathan W Simons; Hyam I Levitsky; Drew M Pardoll
Use of murine models of cytokine-secreting tumor vaccines to study feasibility and toxicity issues critical to designing clinical trials.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;18(1):1-9.
1995: Constance A Griffin; Ralph Hruban; L A Morsberger; T Ellingham; P P Long; Elizabeth M Jaffee; K M Hauda; S K Bohlander; Charles J Yeo
Consistent chromosome abnormalities in adenocarcinoma of the pancreas.
Cancer research 1995;55(11):2394-9.
1995: Amina S Woods; Alex Yee-Chen Huang; Robert J Cotter; Gary R Pasternack; Drew M Pardoll; Elizabeth M Jaffee
Simplified high-sensitivity sequencing of a major histocompatibility complex class I-associated immunoreactive peptide using matrix-assisted laser desorption/ionization mass spectrometry.
Analytical biochemistry 1995;226(1):15-25.
1995: A J Berns; Shirley Clift; LK Cohen; Ross C Donehower; Glenn Dranoff; K M Hauda; Elizabeth M Jaffee; Audrey Lazenby; Hyam I Levitsky; F F Marshall
Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma.
Human gene therapy 1995;6(3):347-68.
1995: Elizabeth M Jaffee; Drew M Pardoll
Gene therapy: its potential applications in the treatment of renal-cell carcinoma.
Seminars in oncology 1995;22(1):81-91.
1994: Alex Yee-Chen Huang; P Golumbek; M Ahmadzadeh; Elizabeth M Jaffee; Drew M Pardoll; Hyam I Levitsky
Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.
Science (New York, N.Y.) 1994;264(5161):961-5.
1994: Martin G Sanda; S R Ayyagari; Elizabeth M Jaffee; Jonathan I Epstein; S L Clift; LK Cohen; Glenn Dranoff; Drew M Pardoll; Richard C Mulligan; Jonathan W Simons
Demonstration of a rational strategy for human prostate cancer gene therapy.
The Journal of urology 1994;151(3):622-8.
1994: Alex Yee-Chen Huang; P Golumbek; M Ahmadzadeh; Elizabeth M Jaffee; Drew M Pardoll; Hyam I Levitsky
Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses.
Ciba Foundation symposium 1994;187():229-40; discussion 240-4.
1993: P T Golumbek; R Azhari; Elizabeth M Jaffee; Hyam I Levitsky; Audrey Lazenby; K Leong; Drew M Pardoll
Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design.
Cancer research 1993;53(24):5841-4.
1993: Elizabeth M Jaffee; Glenn Dranoff; LK Cohen; K M Hauda; Shirley Clift; Fray F Marshall; Richard C Mulligan; Drew M Pardoll
High efficiency gene transfer into primary human tumor explants without cell selection.
Cancer research 1993;53(10 Suppl):2221-6.
1993: Glenn Dranoff; Elizabeth M Jaffee; Audrey Lazenby; P Golumbek; Hyam I Levitsky; K Brose; V Jackson; H Hamada; Drew M Pardoll; Richard C Mulligan
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(8):3539-43.
1992: P T Golumbek; Fayez M Hamzeh; Elizabeth M Jaffee; Hyam I Levitsky; Paul S Lietman; Drew M Pardoll
Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;12(4):224-30.
1992: Marc S Ernstoff; Elizabeth M Jaffee; T Oeler
The development and characterization of a natural killer cell-resistant human renal cell carcinoma cell line.
Natural immunity 1992;11(1):17-25.
1985: HW Murray; B Y Rubin; S M Carriero; A M Harris; Elizabeth M Jaffee
Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(3):1982-8.